Close Menu

NEW YORK — OpGen reported after the close of the market Wednesday a 70 percent year-over-year increase in its third quarter revenues, beating its preliminary revenue announcement of a 54 percent increase.

For the three-month period ended Sept. 30, OpGen posted revenues of $1.1 million versus year-ago revenues of $648,220, beating Wall Street estimates of $1 million in revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.